ArticleHematological oncology2022

Isatuximab plus carfilzomib and dexamethasone versus carfilzomib and dexamethasone in elderly patients with relapsed multiple myeloma: IKEMA subgroup analysis.

Thierry Facon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.